BEHRING
LIVE

Serial Number

79003201

Owner

Hoechst Aktiengesellschaft

Attorney

Scott D. Woldow

Filing Date

Feb 12, 2004

Add to watchlist:

No watchlists yet
View on USPTO

BEHRING Trademark

Serial Number: 79003201 • Registration: 3127022

BEHRING is a trademark filed by Hoechst Aktiengesellschaft on February 12, 2004. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Hoechst GmbH

Brueningstrasse 45
Frankfurt am Main, D-65926 , DE

Entity Type: 03

CSL Behring L.L.C.

1020 First Avenue
King of Prussia, PA 13502

Entity Type: 16

Trademark Details

Filing Date

February 12, 2004

Registration Date

August 8, 2006

Published for Opposition

May 16, 2006

Goods & Services

[ Diagnostic preparations and reagents for medical use; vaccines; ] pharmaceutical preparations for the treatment of hemophilia, blood coagulation disorders and immune system disorders; [ pharmaceutical preparations for the inhibition of blood clots; ] pharmaceutical preparations for promoting wound healing; and pharmaceutical preparations, namely, blood plasma expanders

[ Diagnostic products for use in clinical laboratories, namely, diagnostic systems used to generate diagnostic test results and to measure and test blood and other biological samples, comprised of analyzers, computer hardware, software and documentation, all sold as a unit for coagulation, protein, infectious disease, immunochemistry, chemistry, nucleic diagnostic testing, cancer, fertility, diabetes, cardiac function, thyroid testing, testing for health related conditions, and microbiology testing; medical and clinical diagnostic analyzers for use in specimen testing, drug testing, specimen validity analysis, and for serum toxicology assays; Medical apparatus for clinical and medical diagnostic use, namely, sample tube conveyors for use in the automation of biological sample processing and analysis of information related thereto; and empty container cartridges for clinical laboratory medical use to contain diagnostic reagents ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 5, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 5, 2026 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 26, 2026 APRE
TEAS SECTION 71 RECEIVED
Sep 23, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 8, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 29, 2024 RNWL
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 12, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 12, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 12, 2022 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2021 NREP
CHANGE OF OWNER RECEIVED FROM IB
Dec 5, 2019 CHLD
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
May 23, 2017 CORV
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 7, 2017 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 6, 2017 INPR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2017 CRFA
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Aug 17, 2016 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Aug 17, 2016 15AK
ASSIGNED TO PARALEGAL
Aug 17, 2016 PLGL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 7, 2016 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 6, 2016 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 5, 2016 APRE
TEAS SECTION 71 RECEIVED
Jun 29, 2016 ES71
TEAS SECTION 15 RECEIVED
Jun 29, 2016 E15R
NEW REPRESENTATIVE AT IB RECEIVED
Feb 25, 2016 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
May 1, 2014 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 1, 2014 INPS
INTERNATIONAL REGISTRATION RENEWED
Feb 27, 2014 RNWL
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 11, 2013 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 10, 2013 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
Sep 11, 2012 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Sep 11, 2012 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2012 APRE
REGISTERED-SEC.71 FILED
Aug 7, 2012 71AF
TEAS SECTION 71 RECEIVED
Aug 7, 2012 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2008 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 4, 2007 FICS
FINAL DISPOSITION PROCESSED
Apr 4, 2007 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 27, 2007 FICR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 2, 2006 CRCV
CHANGE OF OWNER RECEIVED FROM IB
Sep 15, 2006 CHLD
REGISTERED-PRINCIPAL REGISTER
Aug 8, 2006 R.PR
PUBLISHED FOR OPPOSITION
May 16, 2006 PUBO
NOTICE OF PUBLICATION
Apr 26, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 27, 2006 PREV
ASSIGNED TO LIE
Mar 24, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2006 TROA
PRIORITY ACTION MAILED
Dec 20, 2005 CPRA
PRIORITY ACTION WRITTEN
Dec 19, 2005 CPRA
AMENDMENT FROM APPLICANT ENTERED
Nov 28, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2005 CRFA
PAPER RECEIVED
Nov 14, 2005 MAIL
NON-FINAL ACTION MAILED
Jun 2, 2005 CNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2005 CNRT
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
May 25, 2005 LIMS
CORRECTION TRANSACTION RECEIVED FROM IB
May 12, 2005 CRCV
FINAL REFUSAL MAILED
Apr 11, 2005 CNFR
FINAL REFUSAL WRITTEN
Apr 8, 2005 CNFR
AMENDMENT FROM APPLICANT ENTERED
Mar 2, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2005 CRFA
PAPER RECEIVED
Feb 11, 2005 MAIL
REFUSAL PROCESSED BY IB
Oct 8, 2004 RFNT
NON-FINAL ACTION MAILED
Sep 10, 2004 CNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2004 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2004 DOCK
NEW APPLICATION ENTERED
Jul 19, 2004 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 15, 2004 REPR